Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Major Depressive Disorder · Migraine · AXSM

Axsome Therapeutics

Axsome Therapeutics patent portfolio — 156 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
One World Trade Center, New York, NY 10007, US HQ
2012 Founded
981 Employees
Public company Type
AXSM · NYSE Ticker
Company details
Status
Public
HQ
One World Trade Center, New York, NY 10007, US
Founded
2012
Employees
981
Programs
1
Drugs
8
Patents
156
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Axsome Therapeutics patents

156 pharmaceutical patents indexed for Axsome Therapeutics. 0 expire within 24 months.

Axsome Therapeutics has 156 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

156 patents

Patent portfolio

Page 4 of 4

  1. US 10369224

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10363312

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10322181

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10307484

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10265324

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10265400

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10265399

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10195278

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10195279

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10137131

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10058614

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9821075

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Axsome Therapeutics have?

156 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Axsome Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.